Skip to main content
MJHS
Navigation
Journal Navigation
Article Navigation
Clinical assessment of risk factors in traumatic brain injury
Natalia Mocanu1,2*, Larisa Rezneac1,2, Natalia Catanoi1,2, Tatiana Malacinschi-Codreanu1,2
https://doi.org/10.52645/MJHS.2026.2.05
Traumatic brain injury remains a leading global health concern with significant social and economic impact. The main causes include traffic accidents, falls, and violence, especially affecting young adults. In the Republic of Moldova, TBI incidence is rising, particularly during the prehospital phase. TBI involves both primary and secondary brain injuries, the latter often resulting from hypoxia, hypotension, or hyperglycemia. These secondary insults critically influence outcomes and are associated with high mortality. Effective prehospital management – focused on stabilizing oxygenation and hemodynamics – is essential in reducing neurological deterioration. Emergency teams play a key role in preventing secondary injury and improving survival.
Correlation between inflammatory hematological indices with severity of pulmonary thromboembolism
Doina Ranga1*, Cornelia Talmaci1, Sergiu Matcovschi1, Natalia Caproș1, Livi Grib2, Andrei Cealan3
https://doi.org/10.52645/MJHS.2026.2.02
Pulmonary thromboembolism (PTE) is a major cardiovascular emergency associated with significant mortality. Systemic inflammation contributes to the pathogenesis of thrombosis and to disease severity, and hematological indices derived from the complete blood count, such as the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR), have been proposed as prognostic predictors.
The spectrum of comorbidities in patients with heart failure with preserved ejection fraction
Irina Cabac-Pogorevici, Adriana Scalețchi*, Valeriu Revenco
https://doi.org/10.52645/MJHS.2026.2.01
Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases and is frequently associated with cardiovascular and metabolic comorbidities. The phenotype of HFpEF patients is heterogeneous, and the impact of comorbidities on prognosis, exercise capacity, and functional status remains insufficiently elucidated.